Additionally, we identified that the sevelamer treatment significantly inhibited the upregulation of the adipogenic Pparg gene in CDHF-fed mice in parallel with the observed improvement in hepatic steatosis (Figure 2F). Here, PPARG is linked to fatty liver disease.